16 results
10-K
2020 FY
PASG
Passage Bio Inc
3 Mar 21
Annual report
8:01am
pricing program; and
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical
424B1
PASG
Passage Bio Inc
22 Jan 21
Prospectus with pricing info
4:31pm
pharmaceutical pricing program; and
a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative
DRS
38cq35a81ee nwqc5585
18 Dec 20
Draft registration statement
12:00am
10-Q
EX-10.1
856a ttihf
11 May 20
Quarterly report
4:06pm
424B4
kps4z08m5hmwza
28 Feb 20
Prospectus supplement with pricing info
4:07pm
S-1
ldi lfnl6kck5y
3 Feb 20
IPO registration
6:39am
S-1
EX-10.6
j1us7 u59
3 Feb 20
IPO registration
6:39am
DRS/A
EX-10.6
8w2wr0r0hm
10 Jan 20
Draft registration statement (amended)
12:00am
DRS/A
zwbftev46e926rx1
10 Jan 20
Draft registration statement (amended)
12:00am
DRS
piakqq9
6 Dec 19
Draft registration statement
12:00am
- Prev
- 1
- Next